Monopar Therapeutics Inc (MNPR) USD0.001

Sell:$22.30Buy:$24.00$1.95 (8.13%)

Prices delayed by at least 15 minutes
Sell:$22.30
Buy:$24.00
Change:$1.95 (8.13%)
Prices delayed by at least 15 minutes
Sell:$22.30
Buy:$24.00
Change:$1.95 (8.13%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
28 October 2024
Karthik RadhakrishnanCFO
Buy
Regular purchase transaction
1,550$16.25$25,187.501,550
30 September 2024
Chandler D. RobinsonCEO
Sell
Tax related
1,918$6.74$12,927.3256,162
30 September 2024
Andrew CittadineCOO
Sell
Tax related
535$6.74$3,605.9039,869
30 June 2024
Chandler D. RobinsonCEO
Sell
Tax related
8,684$0.73$6,348.00265,923
30 June 2024
Andrew CittadineCOO
Sell
Tax related
2,019$0.73$1,475.89193,065
30 June 2024
Kim R TsuchimotoCFO
Sell
Tax related
2,998$0.73$2,191.5457,429
20 June 2024
Andrew CittadineCOO
Buy
Regular purchase transaction
20,508$0.74$15,253.85186,132
18 June 2024
Andrew CittadineCOO
Buy
Regular purchase transaction
12,000$0.86$10,320.00165,624
17 June 2024
Andrew CittadineCOO
Buy
Regular purchase transaction
12,000$0.90$10,798.80153,624
14 June 2024
Andrew CittadineCOO
Buy
Regular purchase transaction
12,000$0.93$11,175.60141,624

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
28 October 2024
Karthik RadhakrishnanCFO
Buy
Regular purchase transaction
1,550$16.25$25,187.501,550
20 June 2024
Andrew CittadineCOO
Buy
Regular purchase transaction
20,508$0.74$15,253.85186,132
30 September 2024
Chandler D. RobinsonCEO
Sell
Tax related
1,918$6.74$12,927.3256,162
14 June 2024
Andrew CittadineCOO
Buy
Regular purchase transaction
12,000$0.93$11,175.60141,624
13 June 2024
Andrew CittadineCOO
Buy
Regular purchase transaction
12,000$0.91$10,920.00129,624

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.